Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer. Twenty-eight patients with advanced colorectal cancer refractory to ...
Salix announced that the FDA has approved Fulyzaq (crofelemer) delayed-release tablets for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy ...
Cancer patients at patient advocacy events voice strong support for company's focus on patient quality of life and the highly neglected need for new therapies for cancer therapy-related diarrhea SAN ...
Please provide your email address to receive an email when new articles are posted on . “Bile acid diarrhea is a common yet underrecognized cause of chronic watery diarrhea. In most countries, ...
SAN FRANCISCO, CA / ACCESSWIRE / October 8, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that a late-breaking abstract evaluating the incidence, severity and management of ...
High levels of a hormone found in cells in the gut could underlie many cases of chronic diarrhea and help explain up to 40% of cases of patients with irritable bowel syndrome with diarrhea, according ...
Shortening the baseline period in hot flash symptom control trials: Comparison of a one-day versus seven-day baseline hot flash diary. Patient and caregiver-reported acceptability of an automatic ...
A team of nurses in the United Kingdom have created a board game to help staff learn and refresh best practices for managing diarrhea patients, according to The Guardian. Nurses from the Newcastle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results